Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 4495969 to 2658 of 2658 entries
Sorted by: Best Match Show Resources per page
Be aware: COVID-19 the new stroke mimicker.

Acta neurologica Belgica

Zuurbier SM, Verschelde HL, Vantyghem S, Yperzeele L, Vanacker P.
PMID: 33200353
Acta Neurol Belg. 2021 Feb;121(1):309-310. doi: 10.1007/s13760-020-01543-8. Epub 2020 Nov 16.

No abstract available.

Cite
Zuurbier SM, Verschelde HL, Vantyghem S, et al. Be aware: COVID-19 the new stroke mimicker. Acta Neurol Belg. 2020;121(1):309-310doi: 10.1007/s13760-020-01543-8.
Zuurbier, S. M., Verschelde, H. L., Vantyghem, S., Yperzeele, L., & Vanacker, P. (2021). Be aware: COVID-19 the new stroke mimicker. Acta neurologica Belgica, 121(1), 309-310. https://doi.org/10.1007/s13760-020-01543-8
Zuurbier, Susanna M, et al. "Be aware: COVID-19 the new stroke mimicker." Acta neurologica Belgica vol. 121,1 (2021): 309-310. doi: https://doi.org/10.1007/s13760-020-01543-8
Zuurbier SM, Verschelde HL, Vantyghem S, Yperzeele L, Vanacker P. Be aware: COVID-19 the new stroke mimicker. Acta Neurol Belg. 2021 Feb;121(1):309-310. doi: 10.1007/s13760-020-01543-8. Epub 2020 Nov 16. PMID: 33200353; PMCID: PMC7669261.
Copy Download .nbib Format: NLM
Early verrucous cell carcinoma of the esophagus: a case report and endoscopic and histologic features.

BMC gastroenterology

Di L, Wu X, Chen Z, Zhu J, Wang H, Tuo B.
PMID: 34906069
BMC Gastroenterol. 2021 Dec 14;21(1):466. doi: 10.1186/s12876-021-02049-0.

BACKGROUND: Verrucous cell carcinoma of the esophagus (VCCE) is an extremely rare tumor and generally detected at advanced stage. Despite of its slow growth and well differentiation, it has very poor prognosis with high mortality. Therefore, early detection is...

Cite
Di L, Wu X, Chen Z, et al. Early verrucous cell carcinoma of the esophagus: a case report and endoscopic and histologic features. BMC Gastroenterol. 2021;21(1):466doi: 10.1186/s12876-021-02049-0.
Di, L., Wu, X., Chen, Z., Zhu, J., Wang, H., & Tuo, B. (2021). Early verrucous cell carcinoma of the esophagus: a case report and endoscopic and histologic features. BMC gastroenterology, 21(1), 466. https://doi.org/10.1186/s12876-021-02049-0
Di, Lianjun, et al. "Early verrucous cell carcinoma of the esophagus: a case report and endoscopic and histologic features." BMC gastroenterology vol. 21,1 (2021): 466. doi: https://doi.org/10.1186/s12876-021-02049-0
Di L, Wu X, Chen Z, Zhu J, Wang H, Tuo B. Early verrucous cell carcinoma of the esophagus: a case report and endoscopic and histologic features. BMC Gastroenterol. 2021 Dec 14;21(1):466. doi: 10.1186/s12876-021-02049-0. PMID: 34906069; PMCID: PMC8672608.
Copy Download .nbib Format: NLM
Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors.

Frontiers in public health

Márquez-González H, Méndez-Galván JF, Reyes-López A, Klünder-Klünder M, Jiménez-Juárez R, Garduño-Espinosa J, Solórzano-Santos F.
PMID: 34386471
Front Public Health. 2021 Jul 27;9:660114. doi: 10.3389/fpubh.2021.660114. eCollection 2021.

The pandemic caused by the new coronavirus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries. The most lethal clinical presentation is respiratory insufficiency, requiring attention in intensive care units (ICU). The most susceptible people...

Cite
Márquez-González H, Méndez-Galván JF, Reyes-López A, et al. Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors. Front Public Health. 2021;9:660114doi: 10.3389/fpubh.2021.660114.
Márquez-González, H., Méndez-Galván, J. F., Reyes-López, A., Klünder-Klünder, M., Jiménez-Juárez, R., Garduño-Espinosa, J., & Solórzano-Santos, F. (2021). Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors. Frontiers in public health, 9660114. https://doi.org/10.3389/fpubh.2021.660114
Márquez-González, Horacio, et al. "Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors." Frontiers in public health vol. 9 (2021): 660114. doi: https://doi.org/10.3389/fpubh.2021.660114
Márquez-González H, Méndez-Galván JF, Reyes-López A, Klünder-Klünder M, Jiménez-Juárez R, Garduño-Espinosa J, Solórzano-Santos F. Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors. Front Public Health. 2021 Jul 27;9:660114. doi: 10.3389/fpubh.2021.660114. eCollection 2021. PMID: 34386471; PMCID: PMC8353107.
Copy Download .nbib Format: NLM
Procedural times in early non-intubated VATS program - a propensity score analysis.

BMC anesthesiology

Metelmann I, Broschewitz J, Pietsch UC, Huschak G, Eichfeld U, Bercker S, Kraemer S.
PMID: 33573604
BMC Anesthesiol. 2021 Feb 11;21(1):44. doi: 10.1186/s12871-021-01270-4.

BACKGROUND: Non-intubated video-assisted thoracic surgery (NiVATS) has been introduced to surgical medicine in order to reduce the invasiveness of anesthetic procedures and avoid adverse effects of intubation and one-lung ventilation (OLV). The aim of this study is to determine...

Cite
Metelmann I, Broschewitz J, Pietsch UC, et al. Procedural times in early non-intubated VATS program - a propensity score analysis. BMC Anesthesiol. 2021;21(1):44doi: 10.1186/s12871-021-01270-4.
Metelmann, I., Broschewitz, J., Pietsch, U. C., Huschak, G., Eichfeld, U., Bercker, S., & Kraemer, S. (2021). Procedural times in early non-intubated VATS program - a propensity score analysis. BMC anesthesiology, 21(1), 44. https://doi.org/10.1186/s12871-021-01270-4
Metelmann, Isabella, et al. "Procedural times in early non-intubated VATS program - a propensity score analysis." BMC anesthesiology vol. 21,1 (2021): 44. doi: https://doi.org/10.1186/s12871-021-01270-4
Metelmann I, Broschewitz J, Pietsch UC, Huschak G, Eichfeld U, Bercker S, Kraemer S. Procedural times in early non-intubated VATS program - a propensity score analysis. BMC Anesthesiol. 2021 Feb 11;21(1):44. doi: 10.1186/s12871-021-01270-4. PMID: 33573604; PMCID: PMC7877094.
Copy Download .nbib Format: NLM
The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review.

Nuclear medicine communications

Quartuccio N, Salem A, Laudicella R, Spataro A, Chiaravalloti A, Caobelli F, Cistaro A, Alongi P, Evangelista L.
PMID: 33741854
Nucl Med Commun. 2021 Aug 01;42(8):839-845. doi: 10.1097/MNM.0000000000001407.

AIM: 18F-Fluorodeoxyglucose (FDG) PET imaging may play an important role in the restaging of patients with small-cell lung cancer (SCLC),, nevertheless, a systematic review of literature was still missing in this setting. The aim of this review was to...

Cite
Quartuccio N, Salem A, Laudicella R, et al. The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review. Nucl Med Commun. 2021;42(8):839-845doi: 10.1097/MNM.0000000000001407.
Quartuccio, N., Salem, A., Laudicella, R., Spataro, A., Chiaravalloti, A., Caobelli, F., Cistaro, A., Alongi, P., & Evangelista, L. (2021). The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review. Nuclear medicine communications, 42(8), 839-845. https://doi.org/10.1097/MNM.0000000000001407
Quartuccio, Natale, et al. "The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review." Nuclear medicine communications vol. 42,8 (2021): 839-845. doi: https://doi.org/10.1097/MNM.0000000000001407
Quartuccio N, Salem A, Laudicella R, Spataro A, Chiaravalloti A, Caobelli F, Cistaro A, Alongi P, Evangelista L. The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review. Nucl Med Commun. 2021 Aug 01;42(8):839-845. doi: 10.1097/MNM.0000000000001407. PMID: 33741854.
Copy Download .nbib Format: NLM
18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL.

Nuclear medicine communications

Garza D, Kandathil A, Xi Y, Subramaniam RM.
PMID: 33741863
Nucl Med Commun. 2021 Aug 01;42(8):907-913. doi: 10.1097/MNM.0000000000001412.

OBJECTIVE: To establish the detection rate of prostate cancer recurrence following definitive therapy by 18F-fluciclovine PET/computed tomography (CT) in patients with biochemical recurrence (BCR) and prostate-specific antigen (PSA) levels less than 2.00 ng/mL.METHODS: In this retrospective study, 78 patients...

Cite
Garza D, Kandathil A, Xi Y, et al. 18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL. Nucl Med Commun. 2021;42(8):907-913doi: 10.1097/MNM.0000000000001412.
Garza, D., Kandathil, A., Xi, Y., & Subramaniam, R. M. (2021). 18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL. Nuclear medicine communications, 42(8), 907-913. https://doi.org/10.1097/MNM.0000000000001412
Garza, Daniel, et al. "18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL." Nuclear medicine communications vol. 42,8 (2021): 907-913. doi: https://doi.org/10.1097/MNM.0000000000001412
Garza D, Kandathil A, Xi Y, Subramaniam RM. 18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL. Nucl Med Commun. 2021 Aug 01;42(8):907-913. doi: 10.1097/MNM.0000000000001412. PMID: 33741863.
Copy Download .nbib Format: NLM
Showing 4495969 to 2658 of 2658 entries